Maynard Um
-
-
-
-
-
-
-
Intensity Therapeutics publishes INT230-6 cancer treatment study results
-
-
-
-
-
-
-
Intensity Therapeutics (INTS) announces positive results on INT230-6 amid phase 2
-
-
-
-
-
-
-
Intensity Therapeutics (INTS) Announces Drug Monitoring Committee Authorized Continuation of Ongoing Phase 3 Sarcoma Trial
-
-
-
-
-
397,136 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

